Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 15, 2018
Accession Number: 0001193125-18-041617
Submission Type: POS AM
CIK: 0001365216
Company Name: Sucampo Pharmaceuticals, Inc.
File Number: 333-218641